<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kumar S</submitter><funding>NIH-NIA</funding><funding>Alzheimer’s Association</funding><funding>NIH-NINDS</funding><funding>NIA NIH HHS</funding><funding>University of Virginia Brain Institute</funding><funding>NINDS NIH HHS</funding><funding>Owens Family Foundation</funding><funding>NIH HHS</funding><funding>Commonwealth of Virginia</funding><pagination>e157433</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9977425</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8(3)</volume><pubmed_abstract>The molecular mediators of cell death and inflammation in Alzheimer's disease (AD) have yet to be fully elucidated. Caspase-8 is a critical regulator of several cell death and inflammatory pathways; however, its role in AD pathogenesis has not yet been examined in detail. In the absence of caspase-8, mice are embryonic lethal due to excessive receptor interacting protein kinase 3-dependent (RIPK3-dependent) necroptosis. Compound RIPK3 and caspase-8 mutants rescue embryonic lethality, which we leveraged to examine the roles of these pathways in an amyloid β-mediated (Aβ-mediated) mouse model of AD. We found that combined deletion of caspase-8 and RIPK3, but not RIPK3 alone, led to diminished Aβ deposition and microgliosis in the mouse model of AD carrying human presenilin 1 and amyloid prec</pubmed_abstract><journal>JCI insight</journal><pubmed_title>Role of the caspase-8/RIPK3 axis in Alzheimer's disease pathogenesis and Aβ-induced NLRP3 inflammasome activation.</pubmed_title><pmcid>PMC9977425</pmcid><funding_grant_id>Related Diseases Research Award Fund</funding_grant_id><funding_grant_id>NA</funding_grant_id><funding_grant_id>Presidential Neuroscience Graduate Fellowship</funding_grant_id><funding_grant_id>AARG-18-566113</funding_grant_id><funding_grant_id>1RF1AG071996-01</funding_grant_id><funding_grant_id>R01NS091617,R01NS106383</funding_grant_id><funding_grant_id>R01 NS106383</funding_grant_id><funding_grant_id>S10 OD025156</funding_grant_id><funding_grant_id>R01 NS091617</funding_grant_id><funding_grant_id>Alzheimer’s</funding_grant_id><funding_grant_id>RF1 AG071996</funding_grant_id><pubmed_authors>Lukens JR</pubmed_authors><pubmed_authors>Oliveira CB</pubmed_authors><pubmed_authors>Kahle AD</pubmed_authors><pubmed_authors>Deppmann CD</pubmed_authors><pubmed_authors>Budhathoki S</pubmed_authors><pubmed_authors>Calhan OY</pubmed_authors><pubmed_authors>Kumar S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Role of the caspase-8/RIPK3 axis in Alzheimer's disease pathogenesis and Aβ-induced NLRP3 inflammasome activation.</name><description>The molecular mediators of cell death and inflammation in Alzheimer's disease (AD) have yet to be fully elucidated. Caspase-8 is a critical regulator of several cell death and inflammatory pathways; however, its role in AD pathogenesis has not yet been examined in detail. In the absence of caspase-8, mice are embryonic lethal due to excessive receptor interacting protein kinase 3-dependent (RIPK3-dependent) necroptosis. Compound RIPK3 and caspase-8 mutants rescue embryonic lethality, which we leveraged to examine the roles of these pathways in an amyloid β-mediated (Aβ-mediated) mouse model of AD. We found that combined deletion of caspase-8 and RIPK3, but not RIPK3 alone, led to diminished Aβ deposition and microgliosis in the mouse model of AD carrying human presenilin 1 and amyloid prec</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2026-05-28T08:09:15.04Z</modification><creation>2025-04-25T16:55:35.536Z</creation></dates><accession>S-EPMC9977425</accession><cross_references><pubmed>36602874</pubmed><doi>10.1172/jci.insight.157433</doi></cross_references></HashMap>